Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. (Q48723425)

15 February 2018

title

Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. (English)

1 reference

15 February 2018

polycystic ovary syndrome

main subject

1 reference

1 reference

Patrizia Monteleone

4

0 references

Paolo G Artini

object named as

Paolo Giovanni Artini

1

0 references

Vito Cela

6

object named as

Vito Cela

1 reference

15 February 2018

Maria Rosaria Parisen Toldin

3

object named as

Maria Rosaria Parisen Toldin

1 reference

15 February 2018

author name string

Maria Ruggiero

2

1 reference

15 February 2018

Massimiliano Monti

5

1 reference

15 February 2018

Andrea Riccardo Genazzani

7

1 reference

15 February 2018

publication date

1 March 2009

1 reference

15 February 2018

published in

Human Fertility

1 reference

15 February 2018

volume

12

1 reference

15 February 2018

issue

1

1 reference

15 February 2018

page(s)

40-44

1 reference

15 February 2018

Concentration of vascular endothelial growth factor released by cultured human luteinized granulosa cells is higher in women with polycystic ovaries than in women with normal ovaries.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Serum vascular endothelial growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Changes in vascular endothelial growth factor levels and the risk of ovarian hyperstimulation syndrome in women enrolled in an in vitro fertilization program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Vascular endothelial growth factor, nitric oxide, and leptin follicular fluid levels correlate negatively with embryo quality in IVF patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Vascular endothelial growth factor, platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 in the follicular fluid of patients undergoing IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Vascular endothelial growth factor: basic science and clinical progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Role of vascular endothelial growth factor in ovarian physiology and pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Prediction of severe ovarian hyperstimulation syndrome by free serum vascular endothelial growth factor concentration on the day of human chorionic gonadotrophin administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity and fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Follicular fluid VEGF levels directly correlate with perifollicular blood flow in normoresponder patients undergoing IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Poor responder-high responder: the importance of soluble vascular endothelial growth factor receptor 1 in ovarian stimulation protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Comparison of ovarian stromal blood flow between fertile women with normal ovaries and infertile women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1beta, interleukin-6, and vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14647270802621358

10.1080/14647270802621358

21 January 2018

Identifiers

DOI

1 reference

15 February 2018

PubMed ID

19330612

1 reference

15 February 2018